Indikationen zur Urinzytologie

Chapter

Zusammenfassung

Die Krebsstatistiken nicht nur der industrialisierten Regionen belegen eine weiter zunehmende Inzidenz urothelialer Tumoren.

Literatur

Zitierte Literatur

  1. Althausen AF, Prout GR, Daly JJ (1976) Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. J Urol 116: 575Google Scholar
  2. Bansidar BJ (2012) Extracolonic manifestations of Lynch Syndrome. Clin Colon Rectal Surg 25: 103-110Google Scholar
  3. Berufsgenossenschaftliche Grundsätze für arbeitsmedizinische Vorsorgeuntersuchungen, 2. Ausg. (1981) Genter, StuttgartGoogle Scholar
  4. Bretton PR, Herr HW, Kimmel M, Fair WR, Whitemore WF jr., Melamed MR (1989) Flow cytometry as a predictor of response and progression in patients with superficial bladder cancer treated with bacillus calmette-guerin. J Urol 141: 1332Google Scholar
  5. Cordonnier JJ, Spjut HJ (1962) Urethral occurrence of bladder carcinoma following cystectomy. J Urol 87: 398Google Scholar
  6. Esposti PL, Edsmyr B, Tribukait B (1978) The role of exfoliative cytology in the management of bladder carcinoma. Urol Res 6: 197Google Scholar
  7. Gowing NFC (1960) Urethral carcinoma associated with cancer of the bladder. Br J Urol 32: 428Google Scholar
  8. Harving N, Wolf H, Melsen F (1988) Positive urinary cytology after tumor resection: an indicator for concomitant carcinoma in situ. J Urol 140: 495Google Scholar
  9. Hermansen DK, Badalament RA, Whitemore WF jr., Fair WF, Melamed MR (1988) Detection of carcinoma in the post-cystectomy urethral remnant by flow cytometric analysis. J Urol 139: 304Google Scholar
  10. Hickey DP, Soloway MS, Murphy WM (1986) Selective urethrectomy following cystprostatectomy for bladder cancer. J Urol 136: 828Google Scholar
  11. Jakse G, Hufnagel B, Hofstädter F, Rübben H (1986) Sequentielle Blasenschleimhautbiopsie beim Urothelkarzinom der Harnblase. Verh Dtsch Ges Urol 37: 200Google Scholar
  12. Koss LG, Deitch D, Ramanthan R, Sherman AB (1985) Diagnostic value of cytology of voided urine. Acta Cytol 29: 810Google Scholar
  13. Koss LG, Melamed MR, Kelly RE (1969) Further cytologic and histologic studies of bladder lesions in workers exposed to paraaminodiphenyl: progress report. J Nat Cancer Inst 43: 233Google Scholar
  14. Koss LG, Melamed MR (Edit) (2006) Koss’ Diagnostic Cytology and its histopathological Bases. Lippincott Williams and Wilkins, Philadelphia (ISBN 0-7817-1928-3)Google Scholar
  15. Koss LG, Melamed MR, Kelly RE (1969) Further cytologic and histologic studies of bladder lesions in workers exposed to paraaminodiphenyl: progress report. J Nat Cancer Inst 43: 233Google Scholar
  16. Müller F, Kraft R, Zingg E (1985) Exfoliative cytology after transurethral resection of superficial bladder tumors. BrJ Urol 57: 530Google Scholar
  17. Murphy WM (2006) What’s the trouble with cytology? J urol 176: 2343–2346Google Scholar
  18. Murphy WM, Emerson LD, Chandler RW, Moinuddin SM, Soloway MS (1986) Flow cytometry versus urinary cytology in the evaluation of patients with bladder cancer. J Urol 136: 815Google Scholar
  19. Porpaczy P, Schramek P (1981) Analgesic nephropathy and phenacetin-induced transitional cell carcinoma - Analysis of 300 patients with long-term comsumption of phenacetin-containing drugs. Eur Urol 7: 349Google Scholar
  20. Rathert P (1987) Paracetamol. Dtsch Med Wochenschr 112: 40Google Scholar
  21. Rathert P, Melchior HJ, Lutzeyer W (1975) Phenacetin: A carcinogen for the urinary tract? J Urol 113: 653Google Scholar
  22. Roth St, Rathert P (1988) Vesiko-enterale Fisteln: Lösungswege eines diagnostischen Dilemmas. Urologe [A] 27: 142Google Scholar
  23. Roth St, Rathert P (1989) Cytological surveillance of carcinoma in situ during and after intravesikal chemotherapy. In: Therapeutic Progress in Urological Cancers. Liss, New York, p 523Google Scholar
  24. Rübben H, Rathert P, Roth St, Hofstädter F, Giani G, Terhorst B, Friedrichs R (1989) Exfoliative Urinzytologie. Harnwegstumorregister, 4. Aufl. Fort- und Weiterbildungskommission der Deutschen Urologen, Arbeitskreis Onkologie, Sektion UrinzytologieGoogle Scholar
  25. Schellhammer PF, Whitemore WF jr. (1976) Transitional cell carcinoma of the urethra in men having cystectomy for bladder cancer. J Urol 115: 56Google Scholar
  26. Seitz M, Zaak D, Knüchel-Clarke R, Stief C (2005) Harnblasentumoren. Die neue WHO-Klassifikation 2004. Urologe 44: 1073–1086Google Scholar

Weiterführende Literatur

  1. Götz M et al. (2014) Fall K.Z. Kongress DGU 2014. P.1.23Google Scholar
  2. Hiroki I, Kikuchi E, Shinodak, Mukai M, Murai M (2007) Carcinoma in situ developing in an ileal neobladder. Urology 69: 576Google Scholar
  3. IARC, Internationale Agentur für Krebsforschung (WHO), Gruppe 1-3Google Scholar
  4. North AC, Lakshmanan Y (2007) Malignancy associated with the use of intestinal segments in the urinary tract. Urol Oncol. 25(2): 165–167Google Scholar
  5. Retz M, Gschwend JE, Maisch P (2016) Kurzform der S3-Leitlinie Harnblasenkarzinom. Urologe 55: 1173–1187Google Scholar
  6. Steinke V et al. (2013) Hereditary Nonpolyposis Colorectal Cancer (HNPCC)/Lynch Syndrome. Dtsch Arztebl Int 110(3): 32–38Google Scholar
  7. Suriano F, Altobelli E, Sergi F, Buscar M (2013) Bladder cancer after radiotherapy for prostate cancer. Rev Urol 15:108–112Google Scholar
  8. Tolkach Y, Kristiansen G (2017) Pathogense urologischer Komplikationen nach Strahlentherapie. Urologe 56: 293–300Google Scholar

Copyright information

© Springer-Verlag GmbH Deutschland 2018

Authors and Affiliations

  1. 1.Institut für UrinzytologieDüsseldorfDeutschland
  2. 2.Lehrstuhl für Urologie der Universität Witten/Herdecke, Helios Kliniken WuppertalDirektor der Klinik für Urologie und KinderurologieWuppertalDeutschland

Personalised recommendations